Neoplasms, Glandular and Epithelial
Recent clinical, regulatory, research and industry developments relating to this disease.
Genomic characterization of thymic epithelial tumors in a real-world dataset.
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
A phase 3 trial of bevacizumab in ovarian cancer.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q3 2027.
Clinical MilestonesViewHide
- 2026-09-16A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Results expected Q3 2027
- 2026-09-01Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsPrimary completion
- 2025-12-16Quality of Life After Primary Transoral Robotic Surgery vs Intensity-modulated Radiotherapy for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma: A Randomized National TrialPrimary completion
- 2026-09-16ClinicalA Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Results expected Q3 2027
- 2026-09-01ClinicalPhase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsPrimary completion
- 2025-12-16ClinicalQuality of Life After Primary Transoral Robotic Surgery vs Intensity-modulated Radiotherapy for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma: A Randomized National TrialPrimary completion
Research-associated treatments
Drugs and agents co-studied with this disease across the research literature — associative, not necessarily established treatments. Number shows shared papers.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes6
- Neoplasms, Glandular and Epithelial2
- Thymoma2
- Thymus Neoplasms2
- Cytoreduction Surgical Procedures1
- Lung Neoplasms1
- Neuroendocrine Tumors1
Leading journals3
- The New England journal of medicine2
- ESMO open1
- Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer1
Leading researchers8
- Ahmad U1
- Alvarez Secord A1
- Appel S1
- Armstrong DK1
- Asamura H1
- Basen-Engquist K1
- Beale P1
- Bille A1
Affiliations (unnormalised)6
- and Thoracic Institute at Cleveland Clinic1
- Ankara University Faculty of Medicine1
- Asan Medical Center1
- Azienda Ospedaliero-Universitaria Pisana1
- Baggiovara Civil Hospital1
- Chaim Sheba Medical Center1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.